China National Medicines Corporation Ltd.’s Net Profit Rose 12% in First Half of 2022

China National Medicines Corporation Ltd. (国药集团药业股份有限公司) (600511.SH) reported a net profit of 932.6 million yuan in the first half of 2022, up 12% year-on-year.

Meanwhile, the company posted 22 billion yuan in revenue, down 0.3% year-on-year.

At the end of the reporting period, it had 27.1 billion yuan in total assets and 12.3 billion yuan in total liabilities, with a liability-to-asset ratio of 45.6%.